Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Video-observed Therapy (vDOT) as a Surrogate to Directly Observed Therapy (DOT) for Active Tuberculosis: a Feasibility Study in a Low Incidence High-income Area

NCT06574529 is registered in ClinicalTrials.gov with Ligue Pulmonaire Genevoise as lead sponsor.

NCT NCT06574529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06574529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Video-observed Therapy (vDOT) as a Surrogate to Directly Observed Therapy (DOT) for Active Tuberculosis: a Feasibility Study in a Low Incidence High-income Area
Lead sponsor
Ligue Pulmonaire Genevoise
Phase
Not applicable
Overall status
Completed
Start date
November 26, 2021
Completion date
May 31, 2024
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis active